Sector ratings Genscript Biotech Corporation
Stocks
1548
KYG3825B1059
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.66 HKD | +4.34% |
|
+2.37% | +18.04% |
| 07-16 | Genscript Associate Reports $657 Million in Carvykti Sales Under License Agreement | MT |
| 06-15 | Genscript Associate Reports Promising Phase 1 Data for LB2501 in B-Cell Lymphoma | MT |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
| 3.92B | AA | ||||||||
| 48.71B | AAA | ||||||||
| 38.35B | - | B | - | - | |||||
| 34.53B | - | ||||||||
| 34.03B | AAA | ||||||||
| 26.77B | A | ||||||||
| 15.64B | - | - | - | - | |||||
| 15.08B | BBB | ||||||||
| 14.18B | AA | ||||||||
| 12.73B | AAA | ||||||||
| 11.61B | - | BBB | - | - | |||||
| 11.16B | AA | ||||||||
| 10.58B | AA | ||||||||
| 10.05B | - | B | - | - | |||||
| 9.14B | - | BBB | - | - | |||||
| 8.69B | A | - | |||||||
| 8.64B | BB | - | |||||||
| 8.75B | - | A | - | - | |||||
| 9.21B | AA | ||||||||
| 8.62B | A | ||||||||
| Average | 17.02B | A | |||||||
| Weighted average by Cap. | A |
- Stock Market
- Stocks
- 1548 Stock
- Sector Genscript Biotech Corporation
- Sector ratings
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















